Disease-modifying polymorphisms and C609Y mutation of RET associated with high penetrance of phaeochromocytoma and low rate of MTC in MEN2A
Mutations of the rearranged during transfection (RET) proto-oncogene, located on chromosome 10q11.2, cause multiple endocrine neoplasia type 2A (MEN2A). Patients with mutations at the codon 609 usually exhibit a high penetrance of medullary thyroid cancer (MTC), but a sufficiently low penetrance of...
Main Authors: | Rowena Speak, Jackie Cook, Barney Harrison, John Newell-Price |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2016-11-01
|
Series: | Endocrinology, Diabetes & Metabolism Case Reports |
Online Access: | https://www.edmcasereports.com/articles/endocrinology-diabetes-and-metabolism-case-reports/10.1530/EDM-16-0093 |
Similar Items
-
RET codon 609 mutations: a contribution for better clinical managing
by: Caterina Mian, et al.
Published: (2012-01-01) -
Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations
by: Rossella Elisei, et al.
Published: (2019-09-01) -
Absence of the RET+3:T allele in the MTC patients
by: Borun Pawel, et al.
Published: (2012-10-01) -
Familial MTC with RET exon 8 Gly533Cys mutation: origin and prevalence of second malignancy
by: Katerina Saltiki, et al.
Published: (2017-10-01) -
Phaeochromocytoma
by: Farndon, J. R.
Published: (1986)